1 March 2024 v2025.25.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activity0falsetruexbrli:purexbrli:sharesiso4217:GBP139075242024-03-012025-02-28139075242025-02-28139075242024-02-2913907524core:WithinOneYear2025-02-2813907524core:WithinOneYear2024-02-2913907524core:ShareCapital2025-02-2813907524core:ShareCapital2024-02-2913907524core:RetainedEarningsAccumulatedLosses2025-02-2813907524core:RetainedEarningsAccumulatedLosses2024-02-2913907524bus:Director12024-03-012025-02-2813907524bus:Director22024-03-012025-02-2813907524bus:RegisteredOffice2024-03-012025-02-281390752412024-03-012025-02-28139075242023-03-012024-02-2913907524countries:EnglandWales2024-03-012025-02-2813907524bus:AuditExemptWithAccountantsReport2024-03-012025-02-2813907524bus:PrivateLimitedCompanyLtd2024-03-012025-02-2813907524bus:SmallEntities2024-03-012025-02-2813907524bus:FullAccounts2024-03-012025-02-28
Company registration number:
13907524
Deltera Healthtech Ltd
Unaudited Filleted Financial Statements for the year ended
28 February 2025
Deltera Healthtech Ltd
Chartered accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Deltera Healthtech Ltd
Year ended
28 February 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements
of
Deltera Healthtech Ltd
for the year ended
28 February 2025
which comprise the income statement, statement of financial position and related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at icaew.com/​regulations.
This report is made solely to the Board of Directors of
Deltera Healthtech Ltd
, as a body. Our work has been undertaken solely to prepare for your approval the
financial statements
of
Deltera Healthtech Ltd
and state those matters that we have agreed to state to the Board of Directors of
Deltera Healthtech Ltd
, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than
Deltera Healthtech Ltd
and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that
Deltera Healthtech Ltd
has kept adequate accounting records and to prepare statutory
financial statements
that give a true and fair view of the assets, liabilities, financial position and loss of
Deltera Healthtech Ltd
. You consider that
Deltera Healthtech Ltd
is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Deltera Healthtech Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
A&C Chartered Accountants
Marsland Chambers
1a Marsland Road
Sale Moor
Cheshire
M33 3HP
United Kingdom
Deltera Healthtech Ltd
Statement of Financial Position
28 February 2025
20252024
Note££
Current assets    
Debtors 5
2,746
 
5,510
 
Cash at bank and in hand
10,242
 
819
 
12,988
 
6,329
 
Creditors: amounts falling due within one year 6
(23,153
)
(11,915
)
Net current liabilities
(10,165
)
(5,586
)
Total assets less current liabilities (10,165 ) (5,586 )
Capital and reserves    
Called up share capital
100
 
100
 
Profit and loss account
(10,265
)
(5,686
)
Shareholders deficit
(10,165
)
(5,586
)
For the year ending
28 February 2025
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
8 May 2025
, and are signed on behalf of the board by:
D Wright
D Goode
DirectorDirector
Company registration number:
13907524
Deltera Healthtech Ltd
Notes to the Financial Statements
Year ended
28 February 2025

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
Marsland Chambers
,
1a Marsland Road
,
Sale Moor
,
Cheshire
,
M33 3HP
, United Kingdom.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4 Average number of employees

The average number of persons employed by the company during the year was
2
(2024: nil).

5 Debtors

20252024
££
Trade debtors
2,736
  -  
Other debtors
10
 
5,510
 
2,746
 
5,510
 

6 Creditors: amounts falling due within one year

20252024
££
Taxation and social security
8,682
  -  
Other creditors
14,471
 
11,915
 
23,153
 
11,915
 

7 Directors' advances, credit and guarantees

The following advances and credits to directors D Wright and D Goode subsisted during the period ended 1 March 2024 and the year ended 28 February 2025.
D Wright
Year ended 29 February 2024
Balance at 01/03/2023: £5,600 owed to the director.
£33 was repaid to the director in the year.
Balance at 29/02/2024: £5,567 owed to the director.
Year ended 28 February 2025
Balance at 01/03/2024: £5,567 owed to the director.
£5,500 was repaid to the director in the year.
Balance at 28/02/2025: £67 owed to the director.
D Goode
Year ended 29 February 2024
Balance at 01/03/2023: £5,000 owed to the director.
£450 was loaned to the company in the year.
Balance at 29/02/2024: £5,450 owed to the director.
Year ended 28 February 2025
Balance at 01/03/2024: £5,450 owed to the director.
£5,500 was repaid to the director in the year.
Balance at 28/02/2025: £50 owed to the company.
T Jamieson
Balance at 01/03/2024: £0.
£600 was loaned to the company in the year.
Balance at 28/02/2025: £600 owed to the director.
The above loans are unsecured, interest free and repayable on demand.

8 Controlling party

During the year ended 28 February 2025, the directors, D Wright and D Goode, controlled the company by virtue of a controlling interest of 100% of the issued ordinary share capital.